PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30909992-0	2019	[Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  : Adenocarcinoma].	Platinum	98-106	erb-b2 receptor tyrosine kinase 2	Homo sapiens	25-29	
30909992-3	2019	The aim of this study is to investigate the efficacy of pemetrexed combined with platinum chemotherapy in patients with HER2-mutant and HER2 wild-type lung adenocarcinoma.	Platinum	81-89	erb-b2 receptor tyrosine kinase 2	Homo sapiens	120-124	
30909992-3	2019	The aim of this study is to investigate the efficacy of pemetrexed combined with platinum chemotherapy in patients with HER2-mutant and HER2 wild-type lung adenocarcinoma.	Platinum	81-89	erb-b2 receptor tyrosine kinase 2	Homo sapiens	136-140	
30909992-13	2019	CONCLUSIONS: HER2-mutant lung adenocarcinoma patients with first-line pemetrexed combined with platinum chemotherapy have greater clinical benefit than HER2 wild-type patients.	Platinum	95-103	erb-b2 receptor tyrosine kinase 2	Homo sapiens	13-17